PROCEPT BioRobotics Corp
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information C
During the quarter ended December 31, 2025, no director or officer of the Company informed us of theadoption ortermination of a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” (as each term is defined in Item 408 of Regulation S-K).
On February 25, 2026, the Compensation Committee approved an additional discretionary cash bonuses for each of Kevin Waters, the Company’s Chief Financial Officer, of approximately $45,000, and Alaleh Nouri, the Company’s Chief Legal Officer and Corporate Secretary, of approximately $39,000, among other direct reports of the Chief Executive
Officer, to support business and leadership continuity during the Company’s leadership transition, each payable on March 20, 2026, subject to continued employment through the payment date.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.